January 25, 2018 / 1:49 PM / 7 months ago

BRIEF-Prokaryotics Announces Licensing Agreement With Merck For Novel Investigational Antibiotic Candidates

Jan 25 (Reuters) - Merck & Co Inc:

* PROKARYOTICS ANNOUNCES LICENSING AGREEMENT WITH MERCK FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CANDIDATES

* PROKARYOTICS - ANNOUNCES LICENSING AGREEMENT WITH MERCK FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CANDIDATES

* PROKARYOTICS - CO GAINS WORLDWIDE RIGHTS TO DEVELOP EARLY PRE-CLINICAL PROGRAMS FOR GRAM-NEGATIVE, GRAM-POSITIVE BACTERIAL CELL ENVELOPE ENZYMES

* PROKARYOTICS - SPECIFIC TERMS OF AGREEMENT WERE NOT DISCLOSED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below